Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 29: 365-368, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by George, P. M.
Right arrow Articles by Abernethy, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by George, P. M.
Right arrow Articles by Abernethy, M. H.

Clinical Chemistry, Vol 29, 365-368, Copyright © 1983 by American Association for Clinical Chemistry

Improved Ellman procedure for erythrocyte cholinesterase

PM George and MH Abernethy

The procedure of Dietz et al. (Clin. Chem. 19: 1309-1313, 1973) for plasma cholinesterase (EC 3.1.1.7) gives a background absorbance of 1.4 A when extended to erythrocyte cholinesterase (EC 3.1.1.8) measurement, because the peak absorbance of the reaction product, 5- thionitrobenzoate, coincides with the hemoglobin Soret band at 410 nm. Consequently, the precision of erythrocyte cholinesterase measurements is poor, and the test is restricted to laboratories with a spectrophotometer having a high signal-to-noise ratio. Use of the detergent benzethonium chloride (Hyamine 1622) instead of quinidine sulfate to stop enzyme action allows readings to be made at 440 nm because the hemoglobin band is shifted to 405 nm and its peak intensity is decreased. Moreover, detergent micelle interactions shift the peak absorbance of the 5-thionitrobenzoate from 410 to 435 nm. Overall, the blank absorbance is decreased to about 0.4 A. This results in an assay that is twice as precise as the previous version and is suited for use in a routine laboratory with a moderate-quality spectrophotometer. Thus erythrocyte cholinesterase measurements can readily be made, to complement plasma cholinesterase in the investigation of exposure to organophosphates.


The following articles in journals at HighWire Press have cited this article:


Home page
 Hum Exp ToxicolHome page
K Soltaninejad, S Shadnia, M Afkhami-Taghipour, R Saljooghi, A Mohammadirad, and M Abdollahi
Blood {beta}-glucuronidase as a suitable biomarker at acute exposure of severe organophosphorus poisoning in human
Human and Experimental Toxicology, December 1, 2007; 26(12): 963 - 966.
[Abstract] [PDF]

Home page
 Hum Exp ToxicolHome page
S. Shadnia, E. Azizi, R. Hosseini, S. Khoei, S. Fouladdel, A. Pajoumand, N. Jalali, and M. Abdollahi
Evaluation of oxidative stress and genotoxicity in organophosphorus insecticide formulators
Human and Experimental Toxicology, September 1, 2005; 24(9): 439 - 445.
[Abstract] [PDF]

Home page
 Hum Exp ToxicolHome page
M. Akhgari, M. Abdollahi, A. Kebryaeezadeh, R. Hosseini, and O. Sabzevari
Biochemical evidence for free radicalinduced lipid peroxidation as a mechanism for subchronic toxicity of malathion in blood and liver of rats
Human and Experimental Toxicology, April 1, 2003; 22(4): 205 - 211.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.